| Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions (NCT04172922) | Nemours Children's Clinic | 2020-04-01 |
| A Study of MSB0254 Injection in Advanced Solid Tumors (NCT04381325) | Suzhou Transcenta Therapeutics Co., Ltd. | 2020-04-01 |
| Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma (NCT04260360) | NanOlogy, LLC | 2020-04-01 |
| Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment (NCT02967250) | University of Minnesota | 2020-04-01 |
| Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults (NCT04343547) | Daewoong Pharmaceutical Co. LTD. | 2020-04-01 |
| Alpha-Bisabolol Gel With Antihistamine Action (NCT05022108) | Universidade do Vale do Sapucai | 2020-04-01 |
| A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma (FUMANBA-1) (NCT05066646) | Nanjing IASO Biotechnology Co., Ltd. | 2020-04-01 |
| Clinical Use of Stem Cells for the Treatment of Covid-19 (NCT04392778) | SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi | 2020-04-01 |
| rTMS to Improve Cognition in Parkinson's (NCT03836950) | VA Office of Research and Development | 2020-04-01 |
| The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects (NCT04596007) | Sunshine Lake Pharma Co., Ltd. | 2020-04-01 |
| Efficacy of Combining an Inferior Alveolar Nerve Block With a Buccal Infiltration (NCT06276842) | CIMS Dental College | 2020-04-01 |
| Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy (NCT04333004) | Xiaorong Dong | 2020-04-01 |
| Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 (NCT04392141) | Kermanshah University of Medical Sciences | 2020-04-01 |
| Application of Desferal to Treat COVID-19 (NCT04333550) | Kermanshah University of Medical Sciences | 2020-04-01 |
| Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease (NCT04352803) | Regeneris Medical | 2020-04-01 |
| Eptinezumab in Healthy Japanese Subjects (NCT04336449) | H. Lundbeck A/S | 2020-04-01 |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets (NCT04275050) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-04-01 |
| Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate (NCT04656067) | Egymedicalpedia | 2020-04-01 |
| GDNF Gene Therapy for Parkinson's Disease (NCT04167540) | Brain Neurotherapy Bio, Inc. | 2020-04-01 |
| A Study of QL1706 in Subjects With Advanced Malignant Tumor (NCT04296994) | Qilu Pharmaceutical Co., Ltd. | 2020-03-31 |
| Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma (NCT04022980) | Wake Forest University Health Sciences | 2020-03-31 |
| Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma (NCT04156828) | University of Washington | 2020-03-31 |
| COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies (NCT04354246) | Compugen Ltd | 2020-03-31 |
| A Study of HBM9161 in NMOSD Patients (NCT04227470) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-03-31 |
| A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248 (NCT04617509) | Gesynta Pharma AB | 2020-03-31 |
| A Through QT/QTc Study of KW-6356 (NCT04342273) | Kyowa Kirin Co., Ltd. | 2020-03-31 |
| Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia (NCT04325737) | Sumitomo Pharma Co., Ltd. | 2020-03-31 |
| A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants (NCT04330248) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2020-03-31 |
| A Trial of SHR-1701 in Subjects With Advanced Solid Tumors (NCT04324814) | Atridia Pty Ltd. | 2020-03-31 |
| TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers (NCT04306900) | Trishula Therapeutics, Inc. | 2020-03-30 |
| A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma (NCT04108325) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2020-03-30 |
| Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab" (NCT04325009) | Dong-A ST Co., Ltd. | 2020-03-30 |
| A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults (NCT03751969) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2020-03-30 |
| Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects (NCT04464681) | Kitasato University | 2020-03-30 |
| Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia (NCT04344548) | Universidad Nacional de Colombia | 2020-03-30 |
| the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 (NCT04623814) | Sunshine Lake Pharma Co., Ltd. | 2020-03-30 |
| PK and Safety of SI-722 in IC/BPS (NCT04208087) | Seikagaku Corporation | 2020-03-30 |
| To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (NCT04389775) | Sciwind Biosciences APAC CO Pty. Ltd. | 2020-03-29 |
| LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients (NCT05925140) | Lebanese University | 2020-03-28 |
| SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04282070) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-27 |
| TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia (NCT04323657) | TCR2 Therapeutics | 2020-03-27 |
| Woebot for Substance Use Disorders (NCT04096001) | Woebot Health | 2020-03-26 |
| Phase 1 Study of Pemigatinib in Patients With Advanced Malignancies With FGF/FGFR Alterations (NCT04258527) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-03-26 |
| Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab (NCT04276493) | BeiGene | 2020-03-26 |
| A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 (NCT04258865) | Chong Kun Dang Pharmaceutical | 2020-03-25 |
| A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment (NCT04241549) | OncoVerity, Inc. | 2020-03-25 |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT04202003) | TJ Biopharma Co., Ltd. | 2020-03-25 |
| T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma (NCT04662099) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2020-03-25 |
| Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies (NCT04277637) | BeOne Medicines | 2020-03-24 |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (NCT04030195) | Precision BioSciences, Inc. | 2020-03-24 |
| Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis (NCT04179760) | SCM Lifescience Co., LTD. | 2020-03-24 |
| A Study to Evaluate Safety, Tolerability, and Bioavailability of Subcutaneous Lirentelimab (AK002) in Adult Healthy Volunteers (NCT04324268) | Allakos Inc. | 2020-03-23 |
| Clinical and Radiographic Outcome of Regeneration in Immature Permanent Human Teeth Using a New Scaffold (NCT06812351) | Ain Shams University | 2020-03-22 |
| Pain Control in Dentin Hypersensitivity in Patients With MIH (NCT04268238) | University of Nove de Julho | 2020-03-20 |
| Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) (NCT04554992) | The Methodist Hospital Research Institute | 2020-03-20 |
| A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults (NCT04268420) | U.S. Army Medical Research and Development Command | 2020-03-20 |
| A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers (NCT04358523) | Ascletis Pharmaceuticals Co., Ltd. | 2020-03-20 |
| A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults (NCT04296279) | U.S. Army Medical Research and Development Command | 2020-03-20 |
| A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers (NCT04321980) | Orpheris, Inc. | 2020-03-19 |
| FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies (NCT04245722) | Fate Therapeutics | 2020-03-19 |
| TAEST16001 in the Treatment of Soft Tissue Sarcoma (NCT04318964) | Sun Yat-sen University | 2020-03-19 |
| Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers. (NCT04260373) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-19 |
| Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects (NCT04309526) | Nucorion Pharmaceuticals, Inc. | 2020-03-18 |
| Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies (NCT04181788) | Pfizer | 2020-03-18 |
| Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer (NCT04220775) | M.D. Anderson Cancer Center | 2020-03-18 |
| NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors (NCT04270461) | Jiujiang University Affiliated Hospital | 2020-03-17 |
| Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors (NCT04266912) | M.D. Anderson Cancer Center | 2020-03-17 |
| Trial of Oxaloacetate in ALS (NCT04204889) | Omar Jawdat | 2020-03-17 |
| Ulixertinib (BVD-523) and Hydroxychloroquine in Patients W Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas (NCT04145297) | University of Utah | 2020-03-17 |
| A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects (NCT06040372) | LG Chem | 2020-03-16 |
| Study of SRF617 in Patients With Advanced Solid Tumors (NCT04336098) | Coherus Oncology, Inc. | 2020-03-16 |
| Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells (NCT04313322) | Stem Cells Arabia | 2020-03-16 |
| Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults (NCT04313127) | CanSino Biologics Inc. | 2020-03-16 |
| Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus (NCT04305587) | Pfizer | 2020-03-16 |
| Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer (NCT03831932) | National Cancer Institute (NCI) | 2020-03-16 |
| Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) (NCT04283461) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-03-16 |
| A Study of LY3478045 in Healthy Participants (NCT04270370) | Eli Lilly and Company | 2020-03-16 |
| IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma (NCT04109456) | InxMed (Shanghai) Co., Ltd. | 2020-03-16 |
| Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) (NCT04170556) | Fundacion Clinic per a la Recerca Biomédica | 2020-03-16 |
| A Study of RC98 in Subjects With Advanced Malignant Solid Tumors (NCT04190823) | RemeGen Co., Ltd. | 2020-03-15 |
| Phase Ib of Recombinant Human Albumin Injection (NCT04701697) | The First Hospital of Jilin University | 2020-03-15 |
| A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457） (NCT04298320) | Yanqiao Zhang | 2020-03-15 |
| Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO (NCT04689893) | Peking Union Medical College Hospital | 2020-03-15 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers. (NCT04277897) | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 2020-03-15 |
| A Study of TAS1440 With ATRA in Subjects With r/r AML (NCT04282668) | Taiho Oncology, Inc. | 2020-03-15 |
| Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia (NCT04289220) | Yan'an Affiliated Hospital of Kunming Medical University | 2020-03-15 |
| Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD) (NCT04922190) | Teachers College, Columbia University | 2020-03-15 |
| Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder (NCT04226352) | Johns Hopkins University | 2020-03-15 |
| First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (NCT04358458) | Genmab | 2020-03-13 |
| A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT04230473) | Juventas Cell Therapy Ltd. | 2020-03-13 |
| A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677 (NCT04268394) | Celgene | 2020-03-13 |
| Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant (NCT04022239) | M.D. Anderson Cancer Center | 2020-03-13 |
| A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults (NCT04306302) | Janssen Pharmaceutical K.K. | 2020-03-13 |
| Ribociclib and Spartalizumab in R/M HNSCC (NCT04213404) | National Taiwan University Hospital | 2020-03-13 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants (NCT05099822) | Celgene | 2020-03-13 |
| A Trial of SHR6390 in Healthy Caucasian Volunteers (NCT04301804) | Atridia Pty Ltd. | 2020-03-12 |
| A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects (NCT04322552) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-12 |
| A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers (NCT04313647) | Ruijin Hospital | 2020-03-12 |
| Natural Killer Cell (CYNK-001) Infusions in Adults with AML (NCT04310592) | Celularity Incorporated | 2020-03-12 |
| A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations (NCT04094610) | Turning Point Therapeutics, Inc. | 2020-03-12 |